19/11/2025
The Plasma Protein Therapeutics Association (PPTA) welcomes the recent Position Paper of the Hellenic Association of Pharmaceutical Companies (SFEE) on the establishment of data informed European-aligned framework for plasma collection in Greece. The proposals put forward by SFEE represent an important step toward ensuring that national policies reflect both patient needs as well as sustainable, resilient health care policies.
As a global trade association, representing the leading manufacturers of plasma-derived medicines and plasma collectors, PPTA stands ready to collaborate with the Hellenic Association of Pharmaceutical Companies (SFEE)and all stakeholders involved in shaping a comprehensive national framework for plasma-derived medicinal products (PDMPs), including plasma collection.
With long-standing international and technical expertise in plasma collection and fractionation, PPTA supports efforts that create or strengthen national frameworks consistent with the European objective for open strategic autonomy to safeguarding supply security and uninterrupted patient access, while also upholding the highest standards of safety, quality, and donation practices.
Marilena Vrana, Vice President of Public Affairs& EU Operations at the Plasma Protein Therapeutics Association (PPTA Europe), states the following:
“PPTA welcomes and supports Hellenic Association of Pharmaceutical Companies' (SFEE)efforts to highlight and address the pressing challenge of insufficient plasma collection within Europe. The alignment between our organizations marks a significant step forward, underscoring the need for a data informed and effective framework that strengthens Europe’s plasma autonomy and safeguards the resilience of the Greek health care system.”
PPTA and its members share a common vision to address the growing and unmet needs of patients who depend on plasma-derived therapies, and to strengthen Europe’s capacity to secure adequate and reliable access to lifesaving PDMPs. PPTA remains committed to constructive dialogue and to supporting initiatives that enhance plasma collection, protect donor and patient well-being, and contribute to the resilience of health care systems in Greece and across Europe.
Read the statement in Greek.